Not provided
Not provided
Not provided
Not provided
Lack of enrollment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Actelion | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
The researchers are investigating if changing an individual's behaviors may have an impact on outcomes for patients with pulmonary arterial hypertension (PAH). This research will test the efficacy of a home-based exercise program to improve exercise tolerance and physical activity.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Usual Care | Active Comparator | Usual care administered at the Pulmonary Arterial Hypertension (PAH) clinic at the University of Michigan. |
|
| Home-based exercise program | Experimental | Home-based individualized exercise program based on heart rate reserve (HRR). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Usual Care | Behavioral | Usual care |
| |
| Home-based exercise program |
| Measure | Description | Time Frame |
|---|---|---|
| Efficacy of a home-based exercise training as measured by change in six-minute walk distance | Distance measured in meters | Baseline, 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Efficacy of a home-based exercise training as measured by change in six-minute walk distance | Distance measured in meters | Baseline, 6 months |
| Change in physical activity as measured by daily activity captured using the pedometer step count |
| Measure | Description | Time Frame |
|---|---|---|
| Change in heart rate recovery | Baseline, 12 weeks | |
| Change in echocardiographic assessment of right ventricle size | Baseline, 12 weeks | |
| Change in echocardiographic assessment of right ventricle function |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas Cascino, MD | University of Michigan | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Michigan | Ann Arbor | Michigan | 48109 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000081029 | Pulmonary Arterial Hypertension |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D006976 | Hypertension, Pulmonary |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
An independent statistician will develop the randomization schedule and an unblinded study team member will document and maintain the treatment assignment log. The investigators will be adjusting the exercise regimens of those randomized to the exercise program and are unable to be blinded. All patients will receive weekly telephone calls to review activity logs. Outcomes included in the primary and secondary analysis will be blinded as possible. The staff performing the 6-minute walk test (6MWT) and interpreting echocardiograms will be blinded to the group assignment.
| Behavioral |
Home-based program determined by exercise physiologist |
|
average daily step counts measured by a pedometer
| Baseline, 12 weeks |
| Change in physical activity as measured by daily activity captured using the pedometer step count | average daily step counts measured by a pedometer | Baseline, 6 months |
| Efficacy of a home-based exercise training as measured by change in treadmill exercise time | Baseline, 12 weeks |
| Efficacy of a home-based exercise training as measured by change in survey score from the EuroQol five dimension, five level (EQ-5D-5L) questionnaire. | Health related quality of life assessed using the EuroQol EQ-5D-5L. There is a descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions. The survey visual analog scale (VAS) records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. The users guide gives details of the scoring system: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L\_UserGuide\_2015.pdf | Baseline, 12 weeks |
| Efficacy of a home-based exercise training as measured by change in survey score from the EuroQol five dimension, five level (EQ-5D-5L) questionnaire. | Health related quality of life assessed using the EuroQol EQ-5D-5L. There is a descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions. The survey visual analog scale (VAS) records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. The users guide gives details of the scoring system: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L\_UserGuide\_2015.pdf | Baseline, 6 months |
| Efficacy of a home-based exercise training as measured by change in survey score The Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) | PAH-SYMPACT (Pulmonary Arterial Hypertension-Symptoms and Impact) is a self-rating questionnaire to assess symptoms and their physical and cognitive/emotional impact. The PAH-SYMPACT™ questionnaire consists of four domains: Cardiopulmonary Symptoms Domain (scored 0-24), Cardiovascular Symptoms Domain (scored 0-20), Physical Impacts Domain (scored 0-28), and the Cognitive/Emotional Impacts Domain (scored 0-16). In each domain a higher score indicates worse symptoms. | Baseline, 12 weeks |
| Efficacy of a home-based exercise training as measured by change in survey score The Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) | PAH-SYMPACT (Pulmonary Arterial Hypertension-Symptoms and Impact) is a self-rating questionnaire to assess symptoms and their physical and cognitive/emotional impact. The PAH-SYMPACT™ questionnaire consists of four domains: Cardiopulmonary Symptoms Domain (scored 0-24), Cardiovascular Symptoms Domain (scored 0-20), Physical Impacts Domain (scored 0-28), and the Cognitive/Emotional Impacts Domain (scored 0-16). In each domain a higher score indicates worse symptoms. | Baseline, 6 months |
| Efficacy of a home-based exercise training as measured by change in survey score International Physical Activity Questionnaire Short Form (IPAQ-SF) | The IPAQ-SF is 4 generic item questionnaire (7 questions). About physical activity time in the past 7 days. | Baseline, 12 weeks |
| Efficacy of a home-based exercise training as measured by change in survey score International Physical Activity Questionnaire Short Form (IPAQ-SF) | The IPAQ-SF is 4 generic item questionnaire (7 questions). About physical activity time in the past 7 days. | Baseline, 6 months |
| Efficacy of a home-based exercise training as measured by change in survey score Patient Health Questionnaire (PHQ)-8 | The PHQ-8 questionnaire about depression and is 8 items long. Each question ranges from 0 (not at all) to 3 (nearly every day) for a total possible score of 24 where higher score means more burdensome. | Baseline, 12 weeks |
| Efficacy of a home-based exercise training as measured by change in survey score Patient Health Questionnaire (PHQ)-8 | The PHQ-8 questionnaire about depression and is 8 items long. Each question ranges from 0 (not at all) to 3 (nearly every day) for a total possible score of 24 where higher score means more burdensome. | Baseline, 6 months |
| Efficacy of a home-based exercise training as measured by change in World Health Organization (WHO) functional class | The World Health Organization (WHO) functional class system was created to define the severity of an individual's symptoms and how they impact on day-to-day activities. The functional classes range from I to IV with IV having worse daily impairments. | Baseline, 12 weeks |
| Efficacy of a home-based exercise training as measured by change in World Health Organization (WHO) functional class | The World Health Organization (WHO) functional class system was created to define the severity of an individual's symptoms and how they impact on day-to-day activities. The functional classes range from I to IV with IV having worse daily impairments. | Baseline, 6 months |
| Baseline, 12 weeks |
| Percent change in brain natriuretic peptide | Baseline, 12 weeks |
| Change in number of low risk criteria | Criteria include: World Health Organization (WHO) functional class I/II, six-minute walk distance >440 m, brain natriuretic peptide (BNP) <50) | Baseline, 12 weeks |
| Frequency of completion of activity logs | Up to 12 weeks |
| Frequency of completion of weekly telephone follow-ups | Up to 12 weeks |
| Number of low risk criteria | Criteria include: World Health Organization (WHO) functional class I/II, six-minute walk distance >440 m, brain natriuretic peptide (BNP) <50 | 6 months |
| Number of hospitalizations for pulmonary hypertension | 12 weeks |
| Number of hospitalizations for pulmonary hypertension | 6 months |
| Frequency of Death | Up to 12 weeks |
| Frequency of Death | Up to 6 months |
| Frequency worsening WHO functional class | WHO functional class higher than previously noted. The World Health Organization (WHO) functional class system was created to define the severity of an individual's symptoms and how they impact on day-to-day activities. The functional classes range from I to IV with IV having worse daily impairments. | 12 weeks |
| Frequency worsening World Health Organization (WHO) functional class | WHO functional class higher than previously noted. The WHO functional class system was created to define the severity of an individual's symptoms and how they impact on day-to-day activities. The functional classes range from I to IV with IV having worse daily impairments. | 6 months |
| Frequency of need for escalation of pulmonary hypertension therapy | Escalation implies dose increase is define as increase of existing therapy or addition of new medication for pulmonary arterial hypertension. | Up to 12 weeks |
| Frequency of need for escalation of pulmonary hypertension therapy | Escalation implies dose increase is define as increase of existing therapy or addition of new medication for pulmonary arterial hypertension. | Up to 6 months |
| Frequency of syncope | 12 weeks |
| Frequency of syncope | 6 months |